A specialty pharmaceutical company, Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) based in Nashville, Tennessee, revealed plans to unveil its financial results for the third quarter of 2025 and deliver a comprehensive company update on Tuesday, Nov. 4, 2025, post the market closure.